Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: COMBINATION_PRODUCT: Docetaxel / Capecitabine|COMBINATION_PRODUCT: Capecitabine / Vinorelbine|COMBINATION_PRODUCT: Paclitaxel / Gemcitabine|DRUG: Ribociclib|DRUG: Letrozole OR Anastrozole|DRUG: Goserelin
Sponsor: Novartis Pharmaceuticals